Fenofibrate may reduce CVD in patients with DM, dyslipidemia
(HealthDay)—Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online Dec. 28 in JAMA Cardiology.
Jan 4, 2017
0
0